BCRX — BioCryst Pharmaceuticals, Inc.

BCRXBioCryst Pharmaceuticals, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · biocryst.com

8.290USD-0.96%Mkt Cap: 2.11B USDP/E: —Last update: 2026-05-22

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuramini…

Industry Peers

Drug Manufacturers - Specialty & Generic

SOBI

Swedish Orphan Biovitrum AB (publ)

153.28BSEKP/E 169.8

ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

Elanco Animal Health Incorporated

10.85BUSD—

loading…

Indicators:|

Key Statistics

Company

Market Cap2.11B USD

Enterprise Value2.75B USD

Revenue (TTM)885.72M USD

Gross Profit855.76M USD

Net Income (TTM)263.86M USD

Revenue/Share4.059 USD

Last Price8.290 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees435

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINUS09058V1035

Valuation

P/E (Trailing)—

P/E (Forward)12.31

PEG9.39

EV/EBITDA8.41

EV/Revenue3.10

P/S2.40

P/B-3.84

EPS (TTM)-1.77

EPS (Forward)0.68

52W Range

6.00043% of range11.31

52W High11.31 USD

52W Low6.000 USD

Profitability

Gross Margin97.82%

Oper. Margin-2.45%

EBITDA Margin36.86%

Profit Margin30.16%

ROE-221.45%

ROA51.32%

Growth

Revenue Growth7.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF347.37M USD

CapEx (TTM)2.47M USD

FCF Margin29.85%

FCF Yield12.55%

Net Debt619.68M USD

Net Debt/EBITDA1.90

Balance Sheet

Debt/Equity-3.68

Current Ratio1.91

Quick Ratio1.78

Book Value/Sh-2.1800 USD

Cash/Share0.9380 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.3 (Strong Buy)

Target (Mean)21.30 USD

Target Range13.00 USD – 32.00 USD

# Analysts10

Ownership

Shares Out.254.16M

Float220.85M

Insiders1.15%

Institutions100.94%

Short Interest

Short Ratio9.1d

Short % Float14.83%

Short % Out.14.72%

Shares Short37.42M

Short (prev mo.)35.19M

Technical

SMA 509.186 (-9.8%)

SMA 2007.914 (+4.8%)

Beta0.57

S&P 52W Chg28.31%

Avg Vol (30d)4.45M

Avg Vol (10d)5.63M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—